NCT02083640 - Relative Bioavailability For Palbociclib Formulations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Healthy

Interventions

DRUG

Palbociclib Formulation Reference

125 mg single dose of palbociclib formulation with 16 micrometer API particle size and dissolution level 1, which is representative of the intended commercial hard gelatin capsule.

DRUG

Palbociclib Formulation Test

125 mg single dose of palbociclib formulation with 41 micrometer API particle size and dissolution level 1

DRUG

Palbociclib Formulation Test

125 mg single dose of palbociclib formulation with 16 micrometer API particle size and dissolution level 2

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven